Your browser doesn't support javascript.
loading
Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
Suetsugu, Hiroyuki; Kim, Kwangwoo; Yamamoto, Takuaki; Bang, So-Young; Sakamoto, Yuma; Shin, Jung-Min; Sugano, Nobuhiko; Kim, Ji Soong; Mukai, Masaya; Lee, Yeon-Kyung; Ohmura, Koichiro; Park, Dae Jin; Takahashi, Daisuke; Ahn, Ga-Young; Karino, Kohei; Kwon, Young-Chang; Miyamura, Tomoya; Kim, Jihye; Nakamura, Junichi; Motomura, Goro; Kuroda, Takeshi; Niiro, Hiroaki; Miyamoto, Takeshi; Takeuchi, Tsutomu; Ikari, Katsunori; Amano, Koichi; Tada, Yoshifumi; Yamaji, Ken; Shimizu, Masato; Atsumi, Takashi; Seki, Taisuke; Tanaka, Yoshiya; Kubo, Toshikazu; Hisada, Ryo; Yoshioka, Tomokazu; Yamazaki, Mihoko; Kabata, Tamon; Kajino, Tomomichi; Ohta, Yoichi; Okawa, Takahiro; Naito, Yohei; Kaneuji, Ayumi; Yasunaga, Yuji; Ohzono, Kenji; Tomizuka, Kohei; Koido, Masaru; Matsuda, Koichi; Okada, Yukinori; Suzuki, Akari; Kim, Bong-Jo.
Afiliação
  • Suetsugu H; Laboratory for Bone and Joint Diseases, RIKEN Center for Medical Sciences, Tokyo 108-8639, Japan.
  • Kim K; Laboratory for Statistical and Translational Genetics Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
  • Yamamoto T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
  • Bang SY; Department of Biology, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Sakamoto Y; Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.
  • Shin JM; Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
  • Sugano N; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
  • Kim JS; Hanyang University Institute for Rheumatology Research, Seoul 04763, Korea.
  • Mukai M; Koga Hospital 21, Fukuoka 839-0801, Japan.
  • Lee YK; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
  • Ohmura K; Department of Orthopaedic Medical Engineering, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Park DJ; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
  • Takahashi D; Department of Rheumatology & Clinical Immunology, Sapporo City General Hospital, Hokkaido 060-8604, Japan.
  • Ahn GY; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
  • Karino K; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
  • Kwon YC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
  • Miyamura T; Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.
  • Kim J; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
  • Nakamura J; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.
  • Motomura G; Hanyang University Institute for Rheumatology Research, Seoul 04763, Korea.
  • Kuroda T; Department of Internal Medicine and Rheumatology, National Hospital Organization Kyushu Medical Center, Fukuoka 810-8563, Japan.
  • Niiro H; Hanyang University Institute for Rheumatology Research, Seoul 04763, Korea.
  • Miyamoto T; Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
  • Takeuchi T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
  • Ikari K; Niigata University Health Administration Center, Niigata 950-2181, Japan.
  • Amano K; Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.
  • Tada Y; Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
  • Yamaji K; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Shimizu M; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
  • Atsumi T; Department of Rheumatology & Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama 350-8550, Japan.
  • Seki T; Department of Rheumatology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
  • Tanaka Y; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Kubo T; Hokkaido Medical Center for Rheumatic Diseases, Hokkaido 063-0811, Japan.
  • Hisada R; Department of Orthopaedic Surgery, Showa University School of Medicine, Tokyo 142-8555, Japan.
  • Yoshioka T; Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Yamazaki M; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka 807-8555, Japan.
  • Kabata T; Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
  • Kajino T; Obihiro Kosei Hospital, Hokkaido 080-0024, Japan.
  • Ohta Y; Division of Regenerative Medicine for Musculoskeletal System, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
  • Okawa T; Kido Hospital, Niigata 950-0862, Japan.
  • Naito Y; Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8641, Japan.
  • Kaneuji A; Department of Orthopaedic Surgery, Tonan Hospital, Hokkaido 060-0004, Japan.
  • Yasunaga Y; Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
  • Ohzono K; Orthopedis and Joint Surgery Center, Kurume University Medical Center, Fukuoka 839-0863, Japan.
  • Tomizuka K; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie 514-8507, Japan.
  • Koido M; Department of Orthopaedic Surgery, Kanazawa Medical University, Ishikawa 920-0293, Japan.
  • Matsuda K; Hiroshima Prefectural Rehabilitation Center, Hiroshima 739-0036, Japan.
  • Okada Y; Department of Orthopaedic Surgery, Amagasaki Chuo Hospital, Hyogo 661-0976, Japan.
  • Suzuki A; Laboratory for Statistical and Translational Genetics Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
  • Kim BJ; Laboratory for Statistical and Translational Genetics Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
Hum Mol Genet ; 31(7): 1082-1095, 2022 03 31.
Article em En | MEDLINE | ID: mdl-34850884
ABSTRACT
Osteonecrosis of the femoral head (ONFH) involves necrosis of bone and bone marrow of the femoral head caused by ischemia with unknown etiology. Previous genetic studies on ONFH failed to produce consistent results, presumably because ONFH has various causes with different genetic backgrounds and the underlying diseases confounded the associations. Steroid-associated ONFH (S-ONFH) accounts for one-half of all ONFH, and systemic lupus erythematosus (SLE) is a representative disease underlying S-ONFH. We performed a genome-wide association study (GWAS) to identify genetic risk factors for S-ONFH in patients with SLE. We conducted a two-staged GWAS on 636 SLE patients with S-ONFH and 95 588 non-SLE controls. Among the novel loci identified, we determined S-ONFH-specific loci by comparing allele frequencies between SLE patients without S-ONFH and non-SLE controls. We also used Korean datasets comprising 148 S-ONFH cases and 37 015 controls to assess overall significance. We evaluated the functional annotations of significant variants by in silico analyses. The Japanese GWAS identified 4 significant loci together with 12 known SLE susceptibility loci. The four significant variants showed comparable effect sizes on S-ONFH compared with SLE controls and non-SLE controls. Three of the four loci, MIR4293/MIR1265 [odds ratio (OR) = 1.99, P-value = 1.1 × 10-9)], TRIM49/NAALAD2 (OR = 1.65, P-value = 4.8 × 10-8) and MYO16 (OR = 3.91, P-value = 4.9 × 10-10), showed significant associations in the meta-analysis with Korean datasets. Bioinformatics analyses identified MIR4293, NAALAD2 and MYO16 as candidate causal genes. MIR4293 regulates a PPARG-related adipogenesis pathway relevant to S-ONFH. We identified three novel susceptibility loci for S-ONFH in SLE.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esteroides / Necrose da Cabeça do Fêmur / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esteroides / Necrose da Cabeça do Fêmur / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão